Organogenesis

Organogenesis is a leading regenerative medicine company specializing in advanced wound care and surgical biologics. They generate revenue by developing and commercializing products that promote healing in patients with chronic and acute wounds, as well as those undergoing surgery. Founded in 1985, the company has a rich history of innovation, including the development of Apligraf, the first living, bi-layered cell therapy approved by the FDA. Organogenesis continues to expand its product portfolio and market presence, focusing on improving patient outcomes through cutting-edge regenerative technologies.

Recent Posts by Organogenesis

1-20 of 175